Status:
UNKNOWN
Hypertonic Saline for Outpatient Bronchiolitis
Lead Sponsor:
University Diego Portales
Collaborating Sponsors:
Clínica Vespucio, Santiago, Chile
Conditions:
Bronchiolitis
Respiratory Distress
Eligibility:
All Genders
1-24 years
Phase:
PHASE2
Brief Summary
We will study if small children who become ill with respiratory distress during the RSV epidemic are better relieved with salbutamol nebulizations diluted in hypertonic (3%), instead of normal (0.9%) ...
Detailed Description
In Santiago, Chile, a near collapse of health services is a notorious feature of every winter when vast numbers of small children line for attention because of respiratory distress caused by a probabl...
Eligibility Criteria
Inclusion
- Age 1 to 24 months
- Mild to moderate respiratory distress (Tal score below 9)
- Up to 5 days of respiratory symptoms, including today
- Expiratory wheezing heard on chest auscultation
- Indication of salbutamol nebulization treatment by attending physician
Exclusion
- Two prior episodes of wheezing
- Premature birth (below 38 weeks), if below 6 months of age
- Lobar pneumonia
- Body temperature above 38 degree Celsius
- Use of salbutamol during the previous 6 hours
- Pulse oxymetry reading below 90%
- Congenital heart disease
- Chronic pulmonary disease: Asthma, cystic fibrosis, bronchopulmonary dysplasia
- Other chronic or genetic condition or disease
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2008
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT00696540
Start Date
June 1 2008
End Date
October 1 2008
Last Update
June 12 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clínica Vespucio
Santiago, Chile, 00300